KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Total Current Liabilities (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Total Current Liabilities for 16 consecutive years, with $14.6 billion as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Total Current Liabilities rose 3.13% year-over-year to $14.6 billion, compared with a TTM value of $14.6 billion through Sep 2024, up 3.13%, and an annual FY2023 reading of $14.0 billion, down 17.62% over the prior year.
  • Total Current Liabilities was $14.6 billion for Q3 2024 at Thermo Fisher Scientific, down from $14.8 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $17.0 billion in Q4 2022 and bottomed at $5.5 billion in Q1 2020.
  • Average Total Current Liabilities over 5 years is $11.4 billion, with a median of $12.1 billion recorded in 2022.
  • The sharpest move saw Total Current Liabilities fell 19.92% in 2020, then skyrocketed 72.55% in 2022.
  • Year by year, Total Current Liabilities stood at $10.3 billion in 2020, then skyrocketed by 30.4% to $13.4 billion in 2021, then rose by 26.6% to $17.0 billion in 2022, then fell by 17.62% to $14.0 billion in 2023, then rose by 4.2% to $14.6 billion in 2024.
  • Business Quant data shows Total Current Liabilities for TMO at $14.6 billion in Q3 2024, $14.8 billion in Q2 2024, and $13.9 billion in Q1 2024.